Detail page

Knowledge Web

Person

Michael Merker (1984-)

Arzt

Name	Michael Merker
Time	1984- (Date of birth and death)
Place	Filderstadt (Geburtsort) Deutschland
Profession	Arzt (characteristic profession)
Related	Philipps-Universität Marburg. Fachbereich Medizin (Studium)
Further information	Dissertation Fachbereich Medizin, Univ. Marburg
Record type	Person
GND-Identifier	1021693553
Record ID	1021693553
Involved in show all Retargeting of NK-92 cells against high-risk rhabdomyosarcomas by means of an ERBB2 (HER2/Neu)-specific chimeric antigen receptor ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience The synergistic use of il-15 and il-21 for the generation of nk cells from cd3/cd19-depleted grafts improves their ex vivo expansion and cytotoxic potential against neuroblastoma: Perspective for optimized immunotherapy post haploidentical stem cell transplantation Pre-emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation Relative Effektivität von Droperidol und Metoclopramid zur Prophylaxe von Übelkeit und Erbrechen in der postoperativen Phase : eine quantitative systematische Übersicht

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Michael Merker (1984-)

Retargeting of NK-92 cells against high-risk rhabdomyosarcomas by means of an ERBB2 (HER2/Neu)-specific chimeric antigen receptor

ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma

Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience

The synergistic use of il-15 and il-21 for the generation of nk cells from cd3/cd19-depleted grafts improves their ex vivo expansion and cytotoxic potential against neuroblastoma: Perspective for optimized immunotherapy post haploidentical stem cell transplantation

Pre-emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation

Relative Effektivität von Droperidol und Metoclopramid zur Prophylaxe von Übelkeit und Erbrechen in der postoperativen Phase : eine quantitative systematische Übersicht